台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - a/michigan/45/2015 (h1n1) pdm09 - like strain (a/michigan/45/2015, nymc x-275);;a/singapore/infimh-16-0019/2016 (h3n2)-like virus (a/singapore/infimh-16-0019/2016 , reassortant ivr-186);;b/colorado/06/2017-like virus (b/maryland/15/2016, reassortant nymc bx-69a) - 滅菌懸液注射劑 - 主成分 (each 0.5ml immunizing dose conains:) ; a/singapore/infimh-16-0019/2016 (h3n2)-like virus (a/singapore/infimh-16-0019/2016 , reassortant ivr-186) (8012002468) ug haemagglutinin; a/michigan/45/2015 (h1n1) pdm09 - like strain (a/michigan/45/2015, nymc x-275) (8012002490) ug haemagglutinin; b/colorado/06/2017-like virus (b/maryland/15/2016, reassortant nymc bx-69a) (8012006800) ug haemagglutinin - influenza, inactivated, split virus or surface antigen - 預防流感。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣東洋藥品工業股份有限公司 台北市南港區園區街3之1號3樓 (11821341) - a/wisconsin/67/2022 (h1n1) pdm09 - like virus (a/georgia/12/2022 cvr-167);;a/darwin/6/2021 (h3n2) - like virus (a/darwin/11/2021);;b/austria/1359417/2021 - like virus (b/singapore/wuh4618/2021);;b/singapore/inftt-16-0610/2016 (a b/phuket/3073/2013-like virus) - 懸浮注射劑 - 主成分 (composition of flucelvax quad for nh2019/2020 influenza season (quantity per dose)) ; b/singapore/inftt-16-0610/2016 (a b/phuket/3073/2013-like virus) (8012002484) ug ha; b/austria/1359417/2021 - like virus (b/singapore/wuh4618/2021) (8012006285) ug ha; a/wisconsin/67/2022 (h1n1) pdm09 - like virus (a/georgia/12/2022 cvr-167) (8012018042) ug ha; a/darwin/6/2021 (h3n2) - like virus (a/darwin/11/2021) (8012018051) ug ha - influenza, inactivated, split virus or surface antigen - 適用於6個月以上兒童及成人之主動免疫接種，預防此疫苗所涵蓋之兩種a型及兩種b型流感病毒所引起的流感相關疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - diphtheria toxoid;;tetanus toxoid;;pertussis bordetella;;pertussis toxoid;;filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type ii;;inactivated poliovirus vaccine type iii;;polysaccharide of haemophilus influenzae type b;;conjugated to the tetanus protein - 凍晶注射劑及懸浮注射液 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) diphtheria toxoid….……≧30 iuiu; tetanus toxoid (8008000200) tetanus toxoid..……………≧40 iuiu; conjugated to the tetanus protein (8008000230) 18-30ugug; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) type 1 poliovirus (inactivated)du; inactivated poliovirus vaccine type ii (8012002202) type 2 poliovirus (inactivated)du; inactivated poliovirus vaccine type iii (8012002203) type 3 poliovirus (inactivated)du; polysaccharide of haemophilus influenzae type b (8012020000) ug; filamentous haemagglutinin (9200050300) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus - 適用於出生2個月至7歲孩童的主動免疫接種，以預防白喉、破傷風、百日咳、小兒麻痺及侵襲性b型嗜血桿菌疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - diphtheria toxoid;;tetanus toxoid;;pertussis bordetella;;pertussis toxoid;;filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type ii;;inactivated poliovirus vaccine type iii;;hepatitis b, antigen, surface;;polysaccharide of haemophilus influenzae type b;;conjugated to the tetanus protein - 懸浮注射液 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) diphtheria toxoid….……30lf (≧20iu)iu; tetanus toxoid (8008000200) tetanus toxoid..…………10lf (≧40iu)iu; conjugated to the tetanus protein (8008000230) 22-36μg; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) (mahoney)du; inactivated poliovirus vaccine type ii (8012002202) (mef-1)du; inactivated poliovirus vaccine type iii (8012002203) (saukett)du; polysaccharide of haemophilus influenzae type b (8012020000) (polyribosylribitol phosphate)ug; hepatitis b, antigen, surface (8081211000) ug; filamentous haemagglutinin (9200050300) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - 適用於出生6週以上之嬰兒及幼兒的基礎免疫接種和追加接種，以預防白喉、破傷風、百日咳、b型肝炎、小兒麻痺及b型嗜血桿菌(hib)所導致的侵襲性疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - pertussis toxoid;;diphtheria toxoid;;tetanus toxoid;;pertactin;;filamentous haemagglutinin;;r-dna hepatitis b surface antigen adsorbed (hbsag);;inactivated polio virus -type 1;;inactivated polio virus - type 2;;inactivated polio virus -type 3;;conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed - 凍晶注射劑 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) i.u.; tetanus toxoid (8008000200) i.u.; inactivated polio virus -type 1 (8012003100) du; inactivated polio virus - type 2 (8012003200) du; inactivated polio virus -type 3 (8012003300) du; conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed (8012004000) (10up of prp and 20-; r-dna hepatitis b surface antigen adsorbed (hbsag) (8081223400) ug; filamentous haemagglutinin (9200050300) ug; pertactin (9900066600) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - infanrix hexa 適用於6週大以上之嬰兒及幼童的基礎免疫接種及追加接種，以對抗白喉、破傷風、百日咳、b型肝炎、小兒麻痺及b型嗜血桿菌。

新加坡 - 中文 - HSA (Health Sciences Authority)

infinitus health products (singapore) pte. ltd. - 胶囊

新加坡 - 中文 - HSA (Health Sciences Authority)

infinitus health products (singapore) pte. ltd. - 液体筹备工作(内部使用的)